Hearing Study | FX-322

Can a single dose medication potentially restore lost hearing? We’re working to find out.

The physicians of Albany ENT and Allergy Services are helping to lead the charge and conducting clinical studies regarding FX-322, a new investigational drug that aims to activate and restore cells in the inner ear needed for healthy hearing.

There are no costs for you to participate. If it is determined that you qualify for the study, you will receive all study related care, including medical tests, clinical care, investigational study drug, and study-related travel all at no cost to you.

Your participation in this study will last for up to 10 months, during which you may have up to 8 in person study visits. Participation is completely voluntary and you may discontinue at any time.

Inclusion Criteria

  • You are between the ages of 18 and 65
  • You have a documented medical history of acquired, adult onset, sensiorineural hearing loss associated with noise-induced SNHL or sudden SNHL
  • You received an audiogram at least 6 months ago or longer
  • **other criteria will apply

If you are interested in this study, see if you qualify here.

How does FX-322 work?

FX-322 is a combination of two small molecule drugs that has been developed to potentially restore the hearing hair cells of the inner ear and thus possibly improve hearing. In this study, researchers want to find out if a single dose of FX-322 may improve hearing. FX-322 is given by an injection through your eardrum into the middle ear. The active ingredients diffuse (move) from the middle ear into the inner ear where the hearing hair cells are located. Injections through the eardrum are commonly performed in our offices and are well tolerated.

About Sensorineural Hearing Loss (SNHL)

Sensorineural Hearing Loss (SNHL) results from excessive sound levels, loud sounds for extended periods of time, viral infections, immune system problems, trauma, and exposures to certain medications. When SNHL occurs, it is usually irreversible, and managed with hearing aids or cochlear implants.

Worldwide, an estimated 1.1 billion people are at risk for hearing loss due to exposure to damaging levels of sound, accounting for about 90% of all hearing loss.

How do I learn more?

If you are interested in participating, please visit the study website.